Vanda Pharmaceuticals Inc. (VNDA) vs X4 Pharmaceuticals, Inc. (XFOR)
- Vanda Pharmaceuticals Inc. VNDA 4.03 −4.95%
- X4 Pharmaceuticals, Inc. XFOR 2.59 −1.89%
Vanda Pharmaceuticals Inc. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Vanda Pharmaceuticals Inc. and X4 Pharmaceuticals, Inc. are of similar size ($261.8M and $256.4M). Vanda Pharmaceuticals Inc. grew revenue faster over the last twelve months: 6.02% against −51.7%. Vanda Pharmaceuticals Inc. has the higher net margin (−127.4% vs −568.8%) and the higher return on invested capital (−217.6% vs −226.6%). Across the 17 metrics below, Vanda Pharmaceuticals Inc. leads on 12 and X4 Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | VNDA | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.74% | 81.51% | 65.16% |
| Operating margin | (86.07%) | (554.71%) | 0.00% |
| Net margin | (127.41%) | (568.80%) | 0.00% |
| Free cash flow margin | (70.93%) | (559.95%) | 0.00% |
| Return on equity | (77.81%) | (113.08%) | (56.36%) |
| Return on assets | (53.00%) | (50.32%) | (48.04%) |
| Return on invested capital | (217.59%) | (226.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack